| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |